Invention Grant
- Patent Title: Substituted asymmetric ureas as modulators of ghrelin receptor activity
-
Application No.: US15889589Application Date: 2018-02-06
-
Publication No.: US10577384B2Publication Date: 2020-03-03
- Inventor: Claudio Giuliano , Silvina Garcia Rubio , Antoine Daina , Angelo Guainazzi , Claudio Pietra
- Applicant: HELSINN HEALTHCARE SA
- Applicant Address: CH Lugano/Pazzallo
- Assignee: Helsinn Healthcare SA
- Current Assignee: Helsinn Healthcare SA
- Current Assignee Address: CH Lugano/Pazzallo
- Agent Clark G. Sullivan
- Main IPC: C07D211/58
- IPC: C07D211/58 ; C07F7/08 ; C07D401/14 ; C07D401/12 ; C07D417/14 ; C07D409/14 ; C07D239/26 ; C07D405/12 ; C07D403/12 ; C07D471/04 ; C07D401/06 ; C07D211/60 ; C07D211/94 ; C07D211/96 ; C07D213/00 ; C07D241/12 ; C07D405/14 ; C07D409/12 ; C07D413/12 ; C07D417/12
Abstract:
Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the ghrelin receptor. The compounds have the general Formula I: or pharmaceutically acceptable salts thereof.
Public/Granted literature
- US20190062352A1 SUBSTITUTED ASYMMETRIC UREAS AS MODULATORS OF GHRELIN RECEPTOR ACTIVITY Public/Granted day:2019-02-28
Information query
